EZH2在滤泡淋巴瘤发生机制中的作用

2022-07-12 张会来 MedSci原创

天津医科大学肿瘤医院

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1746925, encodeId=aab91e4692586, content=<a href='/topic/show?id=5fefe188e3' target=_blank style='color:#2F92EE;'>#Ezh2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7188, encryptionId=5fefe188e3, topicName=Ezh2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2a935872940, createdName=fusion, createdTime=Thu Jan 26 16:53:15 CST 2023, time=2023-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027408, encodeId=05b8202e40830, content=<a href='/topic/show?id=adf366592da' target=_blank style='color:#2F92EE;'>#滤泡淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66592, encryptionId=adf366592da, topicName=滤泡淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Wed Apr 26 15:53:15 CST 2023, time=2023-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511321, encodeId=926a151132113, content=<a href='/topic/show?id=0a493e89802' target=_blank style='color:#2F92EE;'>#发生机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37898, encryptionId=0a493e89802, topicName=发生机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=188310331118, createdName=ms6390871039024434, createdTime=Wed Jul 13 09:53:15 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
2023-01-26 fusion

#Ezh2#

80 0
[GetPortalCommentsPageByObjectIdResponse(id=1746925, encodeId=aab91e4692586, content=<a href='/topic/show?id=5fefe188e3' target=_blank style='color:#2F92EE;'>#Ezh2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7188, encryptionId=5fefe188e3, topicName=Ezh2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2a935872940, createdName=fusion, createdTime=Thu Jan 26 16:53:15 CST 2023, time=2023-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027408, encodeId=05b8202e40830, content=<a href='/topic/show?id=adf366592da' target=_blank style='color:#2F92EE;'>#滤泡淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66592, encryptionId=adf366592da, topicName=滤泡淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Wed Apr 26 15:53:15 CST 2023, time=2023-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511321, encodeId=926a151132113, content=<a href='/topic/show?id=0a493e89802' target=_blank style='color:#2F92EE;'>#发生机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37898, encryptionId=0a493e89802, topicName=发生机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=188310331118, createdName=ms6390871039024434, createdTime=Wed Jul 13 09:53:15 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
2023-04-26 charleshjw

#滤泡淋巴瘤#

67 0
[GetPortalCommentsPageByObjectIdResponse(id=1746925, encodeId=aab91e4692586, content=<a href='/topic/show?id=5fefe188e3' target=_blank style='color:#2F92EE;'>#Ezh2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7188, encryptionId=5fefe188e3, topicName=Ezh2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2a935872940, createdName=fusion, createdTime=Thu Jan 26 16:53:15 CST 2023, time=2023-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027408, encodeId=05b8202e40830, content=<a href='/topic/show?id=adf366592da' target=_blank style='color:#2F92EE;'>#滤泡淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66592, encryptionId=adf366592da, topicName=滤泡淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfe313, createdName=charleshjw, createdTime=Wed Apr 26 15:53:15 CST 2023, time=2023-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1511321, encodeId=926a151132113, content=<a href='/topic/show?id=0a493e89802' target=_blank style='color:#2F92EE;'>#发生机制#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37898, encryptionId=0a493e89802, topicName=发生机制)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=188310331118, createdName=ms6390871039024434, createdTime=Wed Jul 13 09:53:15 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
2022-07-13 ms6390871039024434

#发生机制#

59 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

血液科

EZH2在滤泡淋巴瘤发生机制中的作用

相关资讯

科室

工具

服务